Consultazione su potenziali sostanze candidate alla sostituzione
-
Consultazioni
- Consultazioni nell’ambito della procedura di autorizzazione
- Identificazione delle sostanze estremamente problematiche
- Progetto di raccomandazione per l’inclusione nell’elenco delle sostanze soggette ad autorizzazione e consultazione
- Richieste di autorizzazione
- Restrizioni presentate che sono in fase di esame
- Inviti a fare osservazioni e presentare prove
- Proposte di sperimentazione
- Consultazioni relative a classificazione ed etichettatura armonizzate
- Consultazioni mirate su classificazione ed etichettatura armonizzate
- Consultazione in seguito a richiesta del direttore esecutivo dell'ECHA
- Consultazione su potenziali sostanze candidate alla sostituzione
- Consultazione sulla deroga ai criteri di esclusione
- Previous consultations on ECHA’s Executive Director Requests to the Committees
- Consultazioni in seguito alle richieste avanzate dal direttore esecutivo dell’ECHA ai comitati
- Consultazione su un progetto di raccomandazione per la modifica delle voci dell’elenco delle sostanze soggette ad autorizzazione
- Occupational exposure limits - Call for comments and evidence
- Occupational exposure limits – Consultations on OEL recommendation
- Derogations for the protection of cultural heritage
- Proposals for new POPs
- Other calls for comments and evidence
- Consultation on draft recommendation for inclusion in the Authorisation List
Consultazione su potenziali sostanze candidate alla sostituzione
Consultazione su potenziali sostanze candidate alla sostituzione
If an active substance meets any of the criteria for substitution listed in Article 10(1) of the Biocidal Products Regulation (BPR), then the evaluating competent authority may identify the substances as a potential candidate for substitution.
If this is the case, before submitting its opinion on the approval or renewal of the active substance to the Commission, ECHA will launch a consultation on the active substance in question.
During the consultation the following information is made public:
- substance identity (name and EC/CAS numbers)
- product-type(s),
- evaluating competent authority,
- intended uses
- condition(s) of Article 10(1) that are met
This applies to applications for approval or for renewal of approval of active substances, including review programme substances
| Dinotefuran | PT 18 | 605-399-0 | 165252-70-0 | 03/11/2023 | 04/01/2024 | Details |
|
Medetomidine (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (Racemic) |
PT 21 | - | 86347-14-0 | 03/11/2023 | 04/01/2024 | Details |
| N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine) | PT 8 | - | 214710-34-6 | 03/11/2023 | 04/01/2024 | Details |
| 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) | PT 18 | 245-387-9 | 23031-36-9 | 21/11/2023 | 22/01/2024 | Details |
Consultation process
The consultation gathers relevant information on the availability of substitutes or alternatives to the active substance in question. Information on the availability of possible alternatives is highly important to support the comparative assessment that is required for the authorisation of biocidal products containing the active substance (considered as a candidate for substitution).
The consultation lasts for 60 days.
Interested third parties may submit relevant information using a secure web-form.
The information submitted may be non-confidential or confidential. If you claim information to be confidential, you will need to provide a justification. Any information claimed confidential will only be available to members of the Biocidal Products Committee (BPC), the Member State competent authorities and the BPC Secretariat in ECHA.
All non-confidential information submitted during the process will be made available to the BPC members, accredited stakeholders and applicant(s) for the active substance. The non-confidential comments will also be available on the dedicated pages of the ECHA website.
At the end of the consultation period, the Biocidal Products Committee (BPC) will take into account the confidential and non-confidential information received before finalising its opinion.